1.           Introduction

1.1       The Insight Partners Research Report Guidance

1.2       Market Segmentation

2.           Executive Summary

2.1       Key Insights

3.           Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.           North America Molecular Diagnostics Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1         North America PEST Analysis

5.           North America Molecular Diagnostics Market - Key Industry Dynamics

5.1       Key Market Drivers:

5.1.1         Development of New Products and Increase in Demand for Point-of-Care Testing

5.1.2         Surging Prevalence of Associated Diseases

5.2       Market Restraints

5.2.1         Limitations Associated with Molecular Testing

5.3       Market Opportunities

5.3.1         Advancements in Molecular Diagnostics Technologies

5.4       Future Trends

5.4.1         Molecular Diagnostics in Personalized Medicine

5.5       Impact Analysis:

6.           Molecular Diagnostics Market - North America Market Analysis

6.1       North America Molecular Diagnostics Market Revenue (US$ Mn), 2022 – 2030

7.           North America Molecular Diagnostics Market – Revenue and Forecast to 2030 – by Disease Area

7.1       Overview

7.2       North America Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)

7.3       Oncology

7.3.1         Overview

7.3.2         Oncology: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.4       Infectious Disease

7.4.1         Overview

7.4.2         Infectious Disease: North America Molecular Diagnostics Market – Revenue and Forecast to 2030  (US$ Million)

7.5       Genetic Testing

7.5.1         Overview

7.5.2         Genetic Testing: North America Molecular Diagnostics Market – Revenue and Forecast to 2030  (US$ Million)

7.6       Cardiac Diseases

7.6.1         Overview

7.6.2         Cardiac Diseases: North America Molecular Diagnostics Market – Revenue and Forecast to 2030  (US$ Million)

7.7       Immune System Disorders

7.7.1         Overview

7.7.2         Immune System Disorders: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.8       Others

7.8.1         Overview

7.8.2         Others: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.           North America Molecular Diagnostics Market – Revenue and Forecast to 2030 – by Technology

8.1       Overview

8.2       North America Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)

8.3       Polymerase Chain Reaction

8.3.1         Overview

8.3.2         PCR: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.3.2.1            RT-PCR

8.3.2.1.1           Overview

8.3.3         RT-PCR: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.3.3.1            qPCR

8.3.3.1.1           Overview

8.3.4         PCR: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.3.4.1            Multiplex PCR

8.3.4.1.1           Overview

8.3.5         Multiplex PCR: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.3.5.1            Others

8.3.5.1.1           Overview

8.3.6         Others: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.4       Isothermal Nucleic Acid Amplification Technology (INAAT)

8.4.1         Overview

8.4.2         Isothermal Nucleic Acid Amplification Technology (INAAT): North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.5       DNA Sequencing and Next-Generation Sequencing (NGS)

8.5.1         Overview

8.5.2         DNA Sequencing and Next-Generation Sequencing (NGS): North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.6       DNA Microarrays

8.6.1         Overview

8.6.2         DNA Microarrays: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.7       In-Situ Hybridization (ISH)

8.7.1         Overview

8.7.2         In-Situ Hybridization (ISH): North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.8       Others

8.8.1         Overview

8.8.2         Others: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9.           North America Molecular Diagnostics Market – Revenue and Forecast to 2030 – by Product and Services

9.1       Overview

9.2       North America Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)

9.3       Assays and Kits

9.3.1         Overview

9.3.2         Assays and Kits: North America Molecular Diagnostics Market – Revenue and Forecast to 2030  (US$ Million)

9.4       Instruments

9.4.1         Overview

9.4.2         Instruments: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9.5       Services and Software

9.5.1         Overview

9.5.2         Services and Software: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.        North America Molecular Diagnostics Market – Revenue and Forecast to 2030 – by End User

10.1     Overview

10.2     North America Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)

10.3     Hospitals and Clinics

10.3.1       Overview

10.3.2       Hospitals and Clinics: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.4     Diagnostics Laboratories

10.4.1       Overview

10.4.2       Diagnostics Laboratories: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.5     Research and Academic Institutes

10.5.1       Overview

10.5.2       Research and Academic Institutes: North America Molecular Diagnostics Market – Revenue and Forecast to 2030  (US$ Million)

10.6     Others

10.6.1       Overview

10.6.2       Others: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

11.        North America Molecular Diagnostics Market - Country Analysis

11.1     North America Molecular Diagnostics Market, Revenue and Forecast To 2030

11.1.1       Overview

11.1.1.1          North America Molecular Diagnostics Market, by Country

11.1.2       US

11.1.2.1          Overview

11.1.3       US Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)

11.1.4       US Molecular Diagnostics Market, by Disease Area

11.1.5       US Molecular Diagnostics Market, by Technology

11.1.5.1          US Molecular Diagnostics Market, by Polymerase Chain Reaction (PCR)

11.1.6       US Molecular Diagnostics Market, by Product and Services

11.1.7       US Molecular Diagnostics Market, by End User

11.1.8       Canada

11.1.8.1          Overview

11.1.9       Canada Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)

11.1.10    Canada Molecular Diagnostics Market, by Disease Area

11.1.11    Canada Molecular Diagnostics Market, by Technology

11.1.11.1       Canada Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)

11.1.12    Canada Molecular Diagnostics Market, by Product and Services

11.1.13    Canada Molecular Diagnostics Market, by End User

11.1.14    Mexico

11.1.14.1       Overview

11.1.15    Mexico Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)

11.1.16    Mexico Molecular Diagnostics Market, by Disease Area

11.1.17    Mexico Molecular Diagnostics Market, by Technology

11.1.17.1       Mexico Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)

11.1.18    Mexico Molecular Diagnostics Market, by Product and Services

11.1.19    Mexico Molecular Diagnostics Market, by End User

12.        North America Molecular Diagnostics Market Industry Landscape

12.1     Overview

12.2     Growth Strategies Done by the Companies in the Market (%)

12.3     Organic Developments

12.3.1       Overview

12.4     Inorganic Developments

12.4.1       Overview

13.        North America Molecular Diagnostics Market, Key Company Profiles

13.1     Abbott Laboratories

13.1.1       Key Facts

13.1.2       Business Description

13.1.3       Products and Services

13.1.4       Financial Overview

13.1.5       SWOT Analysis

13.1.6       Key Developments

13.2     Agilent Technologies Inc

13.2.1       Key Facts

13.2.2       Business Description

13.2.3       Products and Services

13.2.4       Financial Overview

13.2.5       SWOT Analysis

13.2.6       Key Developments

13.3     Thermo Fisher Scientific Inc

13.3.1       Key Facts

13.3.2       Business Description

13.3.3       Products and Services

13.3.4       Financial Overview

13.3.5       SWOT Analysis

13.3.6       Key Developments

13.4     F. Hoffmann-La Roche Ltd

13.4.1       Key Facts

13.4.2       Business Description

13.4.3       Products and Services

13.4.4       Financial Overview

13.4.5       SWOT Analysis

13.4.6       Key Developments

13.5     Qiagen NV

13.5.1       Key Facts

13.5.2       Business Description

13.5.3       Products and Services

13.5.4       Financial Overview

13.5.5       SWOT Analysis

13.5.6       Key Developments

13.6     bioMerieux SA

13.6.1       Key Facts

13.6.2       Business Description

13.6.3       Products and Services

13.6.4       Financial Overview

13.6.5       SWOT Analysis

13.6.6       Key Developments

13.7     Illumina Inc

13.7.1       Key Facts

13.7.2       Business Description

13.7.3       Products and Services

13.7.4       Financial Overview

13.7.5       SWOT Analysis

13.7.6       Key Developments

13.8     Danaher

13.8.1       Key Facts

13.8.2       Business Description

13.8.3       Products and Services

13.8.4       Financial Overview

13.8.5       SWOT Analysis

13.8.6       Key Developments

13.9     Siemens Healthineers AG

13.9.1       Key Facts

13.9.2       Business Description

13.9.3       Products and Services

13.9.4       Financial Overview

13.9.5       SWOT Analysis

13.9.6       Key Developments

13.10  Novartis AG

13.10.1    Key Facts

13.10.2    Business Description

13.10.3    Products and Services

13.10.4    Financial Overview

13.10.5    SWOT Analysis

13.10.6    Key Developments

13.11  TBG Diagnostics Limited

13.11.1    Key Facts

13.11.2    Business Description

13.11.3    Products and Services

13.11.4    Financial Overview

13.11.5    SWOT Analysis

13.11.6    Key Developments

14.        Appendix

14.1     About Us

14.2     Glossary of Terms

List of Tables

Table 1.             North America Molecular Diagnostics Market Segmentation

Table 2.             US Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area

Table 3.             US Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology

Table 4.             US Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)

Table 5.             US Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services

Table 6.             US Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User

Table 7.             Canada Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area

Table 8.             Canada Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology

Table 9.             Canada Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)

Table 10.          Canada Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services

Table 11.          Canada Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User

Table 12.          Mexico Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area

Table 13.          Mexico Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology

Table 14.          Mexico Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)

Table 15.          Mexico Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services

Table 16.          Mexico Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User

Table 17.          Organic Developments Done By Companies

Table 18.          Inorganic Developments Done By Companies

Table 19.          Glossary of Terms, Molecular Diagnostics Market

List of Figures

Figure 1.           North America - PEST Analysis

Figure 2.           North America Molecular Diagnostics Market - Key Industry Dynamics

Figure 3.           Impact Analysis of Drivers and Restraints

Figure 4.           North America Molecular Diagnostics Market Revenue (US$ Mn), 2022 – 2030

Figure 5.           North America Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)

Figure 6.           Oncology: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 7.           Infectious Disease: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 8.           Genetic Testing: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 9.           Cardiac Diseases: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 10.        Immune System Disorders: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 11.        Others: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 12.        North America Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)

Figure 13.        PCR: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 14.        RT-PCR: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 15.        qPCR: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 16.        Multiplex PCR: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 17.        Others: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 18.        Isothermal Nucleic Acid Amplification Technology (INAAT): North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 19.        DNA Sequencing and Next-Generation Sequencing (NGS): North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 20.        DNA microarrays: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 21.        In-Situ Hybridization (ISH): North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 22.        Others: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 23.        North America Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)

Figure 24.        Assays and Kits: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 25.        Instruments: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 26.        Services and Software: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 27.        North America Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)

Figure 28.        Hospitals and Clinics: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 29.        Ambulatory Surgical Centers: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 30.        Research and Academic Institutes: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 31.        Others: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 32.        Molecular Diagnostics Market, 2022 ($Mn)

Figure 33.        North America Molecular Diagnostics Market, By Key Countries, 2022 And 2030 (%)

Figure 34.        US Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)

Figure 35.        Canada Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)

Figure 36.        Mexico Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)

Figure 37.        Growth Strategies Done by the Companies in the Market (%)